Your browser doesn't support javascript.
loading
Type I-E CRISPR-Cas System as a Defense System in Saccharomyces cerevisiae.
Bindal, Gargi; Amlinger, Lina; Lundgren, Magnus; Rath, Devashish.
Afiliação
  • Bindal G; Applied Genomics Section, Bhabha Atomic Research Centre, Mumbai, India.
  • Amlinger L; Homi Bhabha National Institute, Mumbai, India.
  • Lundgren M; Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
  • Rath D; Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
mSphere ; 7(3): e0003822, 2022 06 29.
Article em En | MEDLINE | ID: mdl-35473305
Defense against viruses and other mobile genetic elements (MGEs) is important in many organisms. The CRISPR-Cas systems found in bacteria and archaea constitute adaptive immune systems that can acquire the ability to target previously unrecognized MGEs. No CRISPR-Cas system is found to occur naturally in eukaryotic cells, but here, we demonstrate interference by a type I-E CRISPR-Cas system from Escherichia coli introduced in Saccharomyces cerevisiae. The designed CRISPR arrays are expressed and processed properly in S. cerevisiae. Targeted plasmids display reduced transformation efficiency, indicative of DNA cleavage. IMPORTANCE Genetic inactivation of viruses and other MGEs is an important tool with application in both research and therapy. Gene editing using, e.g., Cas9-based systems, can be used to inactivate MGEs in eukaryotes by introducing specific mutations. However, type I-E systems processively degrade the target which allows for inactivation without detailed knowledge of gene function. A reconstituted CRISPR-Cas system in S. cerevisiae can also function as a basic research platform for testing the role of various factors in the interference process.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus / Sistemas CRISPR-Cas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus / Sistemas CRISPR-Cas Idioma: En Ano de publicação: 2022 Tipo de documento: Article